The MD-6000 Bladder Scanner is used regularly by urologists, primary care physicians (internal medicine/family practice), gynecologists, hospital units, long term/extended care facilities and in ...

The first targeted drug for a common form of bladder cancer that can be taken at home has been backed for NHS use, offering hope of simpler treatment to hundreds of patients in England.

The subtypes investigated in bladder cancer were CK19, CK20 and CK7 IHC/RT-PCR CK20: 56–46% [98,99]; CK7: 100% [99]; CK1: 93.1% [101] Association of CK19 with UPII detected pN0 patients with ...

A phase 3 trial of Johnson & Johnson's TAR-200 therapy in bladder cancer has failed to show efficacy, although the company is still confident in the potential of the programme. The SunRISe-2 study ...

Buying the right camera, lens, accessory or software to suit your photography is really important. Our product reviews offer independent views with hands-on opinion and honest verdicts aimed to ...

A supplemental biologics license application has been submitted to the FDA for nogapendekin alfa plus Bacillus Calmette-Guérin in papillary non-muscle invasive bladder cancer. ImmunityBio has ...

for the treatment of overactive bladder (OAB).This is the first time that CTAF has addressed this topic.

Click to Subscribe to Get Our Free HollywoodLife Daily Newsletter to get the hottest celeb news. Articles Trending Now ...

Geraldine Pignot. Dr. Pignot discussed Dr. Catto’s presentation “NIAGARA - Surgical outcomes and neoadjuvant safety with perioperative durvalumab for muscle-invasive bladder cancer.” The NIAGARA trial ...

10,842,780 (“the ‘780 patent”) pertaining to the sustained release formulation of mirabegron, which is used for treating overactive bladder (OAB). “The Court passed an order in favour of the innovator ...

The biggest stories of the day delivered to your inbox.